Welcome to Primary Care Pages (PCP), a dedicated portal for General Practitioners. Please register an account with us to access our one-stop resource hub.
Thank you for visiting the Primary Care Pages. Please proceed to log in with your Member ID and password.
Primary Care Pages is enabled with 2FA.
Click here to set up.
Overview of primary care sector
Overview of how AIC can support you in primary care
Find out how these schemes can support your practice
Keep current on issues impacting your practice
One-stop resource for IT solution
Find out how these models can support your practice
Look here for opportunities to equip and collaborate
Quick links to access the portals
An one-stop resource page on COVID 19
Clinical guidelines and resources for holistic care
Care services for your patient
Managing pandemic situations in general practice
Materials to value-add your engagement with patients
Important information impacting your practice
Useful primary care articles catered for you
Stay tune with latest primary care updates
Checkout the latest buzz on primary care deals here
A consolidation of events and trainings organised just for you
For enquiry, feedback and compliment
Update of General Practitioners' particulars
Onsite training for related Primary Care schemes/models
For IDAPE accessor to update particulars
To list your clinic in Singapore Silver Pages
For IDAPE accessor to withdraw from IDAPE
Search for medical support and services
Mission – To develop sustainable, integrated asthma programs with community partners Vision - To provide innovative and high-value asthma care to all asthma patients
Asthma is one of the commonest chronic diseases in Singapore; the prevalence is 5% in adults and 20% in children. To reduce the costs and burden of poorly controlled asthma, the Singapore National Asthma Program (SNAP) has been in place since 2001 to reduce the healthcare burden of uncontrolled asthma. Asthma-related healthcare costs were reduced,1 and asthma mortality in the Singapore population aged 5 to 34 years has fallen from 7 per million population between 1994 and 1998 to 2 per million population between 2006 and 2010.2
However, there is room for improvement. Our asthma-related emergency department visits and hospitalizations are 2-3x higher than other developed countries.3 Preventable asthma deaths in mild asthmatics are still occurring. This is largely because many patients treat asthma, a chronic inflammatory airway disease, as a mild acute viral infection and rely mainly on short-acting beta-agonists (SABA) for temporary symptom relief.4 SABA monotherapy is a double-edged sword: though it provides temporary relief, it can paradoxically worsen airway inflammation and thus asthma control.5 Excessive SABA use* is strongly associated with asthma deaths.6 As concomitant use of ICS can mitigate the side effects of SABA, we hope to work with primary care partners** to change the attitudes and behavior of asthmatics in Singapore, and encourage the use of ICS and self-management for better control.
Since 2018, the SNAP-2 team has extended its work into primary care, to integrate asthma workflows with education efforts via the following initiatives:
We hope to continue working with primary care partners to address existing practice gaps. As 80% of asthma cases are managed in primary care, GPs are well placed to contribute to our vision to deliver high value and cost-effective care to all asthmatics in Singapore, in line with their role as the first and continuous line of care for patients. We look forward to working with all our stakeholders to improve asthma care and outcomes.
More Preventor Less RelieverZero tolerance to Asthma Deaths
Dr Lim Hui Fang
Director Singapore National Asthma Program-2
Senior Consultant, National University Hospital, Singapore
Asst. Professor, Yong Loo Lin School of Medicine, National University of Singapore
*Excessive SABA use associated with increased asthma mortality is defined by the usage of 1- canister every month.** Agency of Integrated Care, College of Family Physicians Singapore, Asthma Allergy Association
References1. Tan NC, Nguyen HV, Lye WK, Sankari U, Nadkarni NV. Trends and predictors of asthma costs: results from a 10-year longitudinal study. Eur Respir J 2016; 47:801-9.2. Lim TK, Chay OM. Fatal asthma in Singapore. Ann Acad Med Singapore 2012; 41:187-8.3. OECD Health Statistics 2015, http://dx.doi.org/10.1787/health-data-en. Accessed 1 Jun 2019.4. Thompson PJ, Salvi S, Lin J, Cho YJ, Eng P, Abdul Manap R, et al. Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong. Respirology 2013; 18:957-67.5. Ameredes BT, Calhoun WJ. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con]. Am J Respir Crit Care Med 2006; 174:965-9; discussion 72-4.6. Levy ML, Andrews R, Buckingham R, Evans H, Francis C, R H. Confidential Enquiry report. London: Royal College of Physicians; 2014. Why asthma still kills: The National Review of Asthma Deaths (NRAD) 2014
Asthma First Aid
View & download (English)
View & download (Chinese)
VIew & download (Malay)
View & download (English)
View & download (Malay)